{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:10:53Z","timestamp":1779912653616,"version":"3.53.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.605288","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T06:52:25Z","timestamp":1605509545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax\u2122 Provides Protection in a Pre-Clinical Schistosomiasis Model"],"prefix":"10.3389","volume":"11","author":[{"given":"Dilhan J.","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McCluskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risini D.","family":"Weeratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momar","family":"Ndao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"B1","article-title":"Schistosomiasis","year":"2014"},{"key":"B2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1159\/000007534","article-title":"Schistosomiasis","volume":"59","author":"El-Garem","year":"1998","journal-title":"Digestion"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0005008","DOI":"10.1371\/journal.pntd.0005008","article-title":"Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial. Satoskar AR, editor","volume":"10","author":"Barda","year":"2016","journal-title":"PloS Negl Trop Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e3286","DOI":"10.1371\/journal.pntd.0003286","article-title":"Clinical Efficacy and Tolerability of Praziquantel for Intestinal and Urinary Schistosomiasis\u2014A Meta-analysis of Comparative and Non-comparative Clinical Trials. Jones MK, editor","volume":"8","author":"Zwang","year":"2014","journal-title":"PloS Negl Trop Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pt.2016.10.010","article-title":"Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials","volume":"33","author":"Siddiqui","year":"2017","journal-title":"Trends Parasitol Elsevier Ltd"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0166-6851(03)00194-4","article-title":"Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase","volume":"131","author":"Sajid","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2015.12.008","article-title":"Immunocapture of circulating Schistosoma mansoni cathepsin B antigen (Sm31) by anti-Sm31 polyclonal antibodies","volume":"65","author":"Gonz\u00e1lez","year":"2016","journal-title":"Parasitol Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2005.06.00","article-title":"Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth","volume":"143","author":"Correnti","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0007490","DOI":"10.1371\/journal.pntd.0007490","article-title":"Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica\u00a0Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model. Yang R, editor","volume":"13","author":"Hassan","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.vetpar.2018.05.008","article-title":"Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep","volume":"258","author":"Norbury","year":"2018","journal-title":"Vet Parasitol Elsevier B.V."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.11.016","article-title":"Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant","volume":"33","author":"Ricciardi","year":"2015","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1444-z","article-title":"A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis","volume":"112","author":"Ricciardi","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0007490","DOI":"10.1371\/journal.pntd.0007490","article-title":"Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica\u00a0Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model","volume":"13","author":"Hassan","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00207","article-title":"AS03-adjuvanted, very-low-dose influenza vaccines induce distinctive immune responses compared to unadjuvanted high-dose vaccines in BALB\/c mice","volume":"6","author":"Yam","year":"2015","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0210009","DOI":"10.1371\/journal.pone.0210009","article-title":"A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities","volume":"14","author":"Hodgins","year":"2019","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0215-8","article-title":"An explant technique for high-resolution imaging and manipulation of mycobacterial granulomas","volume":"15","author":"Cronan","year":"2018","journal-title":"Nat Methods"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin16.215","article-title":"Periostin as a marker of mucosal remodelling in chronic rhinosinusitis","volume":"55","author":"Ebenezer","year":"2017","journal-title":"Rhinol J Rhinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01022\/full","article-title":"Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum","volume":"10","author":"Tang","year":"2019","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms6375","article-title":"Omega-1 knockdown in Schistosoma mansoni eggs by lentivirus transduction reduces granuloma size in vivo","volume":"5","author":"Hagen","year":"2014","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762008005000005","article-title":"A new miracidia hatching device for diagnosing schistosomiasis","volume":"103","author":"Jurberg","year":"2008","journal-title":"Mem Inst Oswaldo Cruz. Fundacao Oswaldo Cruz"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.010","article-title":"Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization","volume":"37","author":"Stark","year":"2019","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/vaccines7040204","article-title":"Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins","volume":"7","author":"Akache","year":"2019","journal-title":"Vaccines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines7040091","article-title":"Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma","volume":"7","author":"Stark","year":"2019","journal-title":"Biomedicines"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.02.041","article-title":"A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations","volume":"561","author":"Jia","year":"2019","journal-title":"Int J Pharm"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - An innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0005443","DOI":"10.1371\/journal.pntd.0005443","article-title":"Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase. Fujiwara RT, editor","volume":"11","author":"Tallima","year":"2017","journal-title":"PloS Negl Trop Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01710","article-title":"Immune mechanisms involved in schistosoma mansoni-Cathepsin B vaccine induced protection in mice","volume":"9","author":"Ricciardi","year":"2018","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.12.7445-7452.2001","article-title":"Role of gamma interferon in the pathogenesis of severe Schistosomiasis in interleukin-4-deficient mice","volume":"69","author":"La Flamme","year":"2001","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.231258498","article-title":"Th1-polarizing immunization with egg antigens correlates with severe exarcebation of immunopathology and death in schistosome infection","volume":"98","author":"Rutitzky","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6406","article-title":"IL-10 and the Dangers of Immune Polarization: Excessive Type 1 and Type 2 Cytokine Responses Induce Distinct Forms of Lethal Immunopathology in Murine Schistosomiasis","volume":"164","author":"Hoffmann","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/vaccines8020162","article-title":"Vaccination with Schistosoma mansoni cholinesterases reduces the parasite burden and egg viability in a mouse model of schistosomiasis","volume":"8","author":"Tedla","year":"2020","journal-title":"Vaccines"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2018.01.004","article-title":"Schistosoma egg-induced liver pathology resolution by Sm-p80-based schistosomiasis vaccine in baboons","volume":"91","author":"Le","year":"2018","journal-title":"Pathology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2007.10.009","article-title":"RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade","volume":"157","author":"Morales","year":"2008","journal-title":"Mol Biochem Parasitol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.57.571","article-title":"Intraspecimen fecal egg count variation in Schistosoma mansoni infection","volume":"57","author":"Engels","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2334-14-210","article-title":"Day-to-day fluctuation of point-of-care circulating cathodic antigen test scores and faecal egg counts in children infected with Schistosoma mansoni in Ethiopia","volume":"14","author":"Degarege","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-3024.1979.tb00715.x","article-title":"Murine Schistosomiasis mansoni: anti-schistosomula antibodies and the IgG subclasses involved in the complement- and eosinophilmediated killing of schistosomula in vitro","volume":"1","author":"Ramalho-Pinto","year":"1979","journal-title":"Parasite Immunol"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.142.12.4422","article-title":"Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni","volume":"142","author":"Khalife","year":"1989","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1371\/journal.pntd.0000290","article-title":"Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine? Bethony J, editor","volume":"2","author":"Wilson","year":"2008","journal-title":"PloS Negl Trop Dis"},{"key":"B42","volume-title":"Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths","author":"Diemert","year":"2012"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.007","article-title":"Regulation of the host immune system by helminth parasites","volume":"138","author":"Maizels","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2009.05.011","article-title":"Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite\u2019s armour","volume":"25","author":"Wilson","year":"2009","journal-title":"Trends Parasitol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(98)00134-5","article-title":"Immune responses to the radiation-attenuated schistosome vaccine: What can we learn from knock-out mice","volume":"65","author":"Wilson","year":"1999","journal-title":"Immunol Lett"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.2005.00764.x","article-title":"Immunity induced by the radiation-attenuated schistosome vaccine","volume":"27","author":"Hewitson","year":"2005","journal-title":"Parasite Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-009-1646-z","article-title":"Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine","volume":"105","author":"Ahmad","year":"2009","journal-title":"Parasitol Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1564","DOI":"10.1371\/journal.pntd.0001564","article-title":"Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2. Hirayama K, editor","volume":"6","author":"Pearson","year":"2012","journal-title":"PloS Negl Trop Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.605288\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T11:10:38Z","timestamp":1697109038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.605288\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2020.605288"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.605288","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"article-number":"605288"}}